NR AAFE
AU Almer,G.; Hainfellner,J.A.; Brücke,T.; Jellinger,K.A.; Kleinert,R.; Bayer,G.; Windl,O.; Kretzschmar,H.A.; Hill,A.F.; Sidle,K.; Collinge,J.; Budka,H.
TI Fatal familial insomnia: a new Austrian family.
QU Brain: A Journal of Neurology 1999 Jan; 122(1): 5-16
IA http://brain.oxfordjournals.org/cgi/content/full/122/1/5
PT journal article
AB We present clinical, pathological and molecular features of the first Austrian family with fatal familial insomnia. Detailed clinical data are available in five patients and autopsy in four patients. Age at onset of disease ranged between 20 and 60 years, and disease duration between 8 and 20 months. Severe loss of weight was an early symptom in all five patients. Four patients developed insomnia and/or autonomic dysfunction, and all five patients developed motor abnormalities. Analysis of the prion protein (PrP) gene revealed the codon 178 point mutation and methionine homozygosity at position 129. In all brains, neuropathology showed widespread cortical astrogliosis, widespread brainstem nuclei and tract degeneration, and olivary 'pseudohypertrophy' with vacuolated neurons, in addition to neuropathological features described previously, such as thalamic and olivary degeneration. Western blotting of one brain and immunocytochemistry in four brains revealed quantitative and regional dissociation between PrPres(the protease resistant form of PrP) deposition and histopathology. In the cerebellar cortex of one patient, PrPres deposits were prominent in the molecular layer and displayed a peculiar patchy and strip-like pattern with perpendicular orientation to the surface. In another patient, a single vacuolated neuron in the inferior olivary nuclei contained prominent intravacuolar granular PrPres deposits, resembling changes of brainstem neurons in bovine spongiform encephalopathy.
MH Adult; Austria; Blotting, Western; Brain/pathology; Case Report; Fatal Outcome; Female; Human; Male; Middle Age; Pedigree; PrPsc Proteins/metabolism; Prions/genetics; Sleep Initiation and Maintenance Disorders/*genetics/*pathology
AD Almer,G. und Brücke,T., Clinic of Neurology, University of Vienna; Hainfellner,J.A. und Budka,H., Austrian Reference Centre for Human Prion Diseases and Institute of Neurology, University of Vienna; Jellinger,K., Ludwig Boltzmann Institute of Clinical Neurobiology, Hospital Lainz, Vienna; Kleinert,R., Institute of Pathology, University of Graz; Bayer,G., Institute of Pathology, Hospital Oberwart, Austria; Windl,O. und Kretzschmar,H.A., Institute of Neuropathology, University of Göttingen, Germany; Hill,A., Sidle,K. und Collinge,J., Imperial College at St Mary's, London, UK
SP englisch
PO England